Lifestyle-related factors in predementia and dementia syndromes

References

• D’Introno A, Panza F, Colacicco AM, Capurso A, Solfrizzi V. Mild cognitive impairment and related entities: role of vascular risk factors. In: Diet and Cognitive Decline. Panza F, Solfrizzi V, Capurso A (Eds). Nova Science Publishers, Inc., NY, USA 1–33 (2004).
   Google Scholar
• American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington, DC, USA (1994).
   Google Scholar
• Qiu C, De Ronchi D, Fratiglioni L. The epidemiology of the dementias: an update. Curr. Opin. Psychiatry20, 380–385 (2007).
   PubMed Web of Science ®Google Scholar
• Whitehouse PJ, Sciulli CG, Mason RM. Dementia drug development: use of information systems to harmonize global drug development. Psychopharmacol. Bull.33, 129–133 (1997).
   PubMedGoogle Scholar
• Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science256, 184–185 (1992).
   PubMed Web of Science ®Google Scholar
• Backman L, Jones S, Berger AK, Laukka EJ, Small BJ. Cognitive impairment in preclinical Alzheimer’s disease: a meta-analysis. Neuropsychology18, 520–531 (2005).
   Google Scholar
• McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944 (1984).
   PubMed Web of Science ®Google Scholar
• Roman GC. Defining dementia: clinical criteria for the diagnosis of vascular dementia. Acta Neurol. Scand. Suppl.178, 6–9 (2002).
   PubMedGoogle Scholar
• Roman GC, Royall DR. Executive control function: a rational basis for the diagnosis of vascular dementia. Alzheimer Dis. Assoc. Disord.13(Suppl. 3), S69–80 (1999).
   PubMedGoogle Scholar
• Sachdev P. Vascular cognitive disorder. Int. J. Geriatr. Psychiatry14, 402–403 (1999).
   PubMed Web of Science ®Google Scholar
• Roman GC, Sachdev P, Royall DR et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J. Neurol. Sci.226, 81–87 (2004).
   PubMed Web of Science ®Google Scholar
• Erkinjuntti T, Inzitari D, Pantoni L et al. Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution? Ann. NY Acad. Sci.903, 262–272 (2000).
   PubMed Web of Science ®Google Scholar
• Panza F, D’Introno A, Colacicco AM et al. Current epidemiology of mild cognitive impairment and other predementia syndromes. Am. J. Geriatr. Psychiatry13, 633–644 (2005).
   PubMed Web of Science ®Google Scholar
• Panza F, D’Introno A, Colacicco AM et al. Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol. Aging27, 933–940 (2006).
   PubMed Web of Science ®Google Scholar
• Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol.56, 303–308 (1999).
   PubMed Web of Science ®Google Scholar
• Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization.Int. Psychogeriatrics6, 63–68 (1994).
   PubMedGoogle Scholar
• Petersen RC, Doody R, Kurz A et al. Current concepts in mild cognitive impairment. Arch. Neurol.58, 1985–1992 (2001).
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Panza F, Colacicco AM et al. Italian Longitudinal Study on Aging Working Group, Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology63, 1882–1891 (2004).
   PubMed Web of Science ®Google Scholar
• Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet357, 169–175 (2001).
   PubMed Web of Science ®Google Scholar
• Goldman WP, Price JL, Storandt M et al. Absence of cognitive impairment or decline in preclinical Alzheimer’s disease. Neurology56, 361–367 (2001).
   PubMed Web of Science ®Google Scholar
• Morris JC, Storandt M, Miller P et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch. Neurol.58, 397–405 (2001).
   PubMed Web of Science ®Google Scholar
• Goate A, Chartier-Harlin MC, Mullan M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature349, 704–706 (1991).
   PubMed Web of Science ®Google Scholar
• Rogaev EI, Sherrington R, Rogaeva EA et al. Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene. Nature376, 775–778 (1995).
   PubMed Web of Science ®Google Scholar
• Sherrington R, Rogaev EI, Liang Y et al. Cloning of a novel gene bearing missense mutations in early onset familial Alzheimer’s disease. Nature375, 754–760 (1995).
   PubMed Web of Science ®Google Scholar
• Panza F, D’Introno A, Colacicco AM et al. Vascular risk and genetics of sporadic late-onset Alzheimer’s disease. J. Neural Transm.111, 69–89 (2004).
   PubMed Web of Science ®Google Scholar
• Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer’s disease. Neurology43, 1467–1472 (1993).
   PubMed Web of Science ®Google Scholar
• American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease. Statement on use of apolipoprotein E testing for Alzheimer disease. JAMA274, 1627–1629 (1995).
   PubMedGoogle Scholar
• Mayeux R, Saunders AM, Shea S et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer’s disease. Alzheimer’s Disease Centers Consortium on Apolipoprotein E and Alzheimer’s disease. N. Engl. J. Med.338, 506–511 (1998).
   PubMed Web of Science ®Google Scholar
• Rosenberg PB, Johnston D, Lyketsos CG. A clinical approach to mild cognitive impairment. Am. J. Psychiatry163, 1884–1890 (2006).
   PubMed Web of Science ®Google Scholar
• Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol.3, 343–353 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang MY, Katzman R, Salmon D et al. The prevalence of dementia and Alzheimer’s disease in Shanghai, China: impact of age, gender, and education. Ann. Neurol.27, 428–437 (1990).
   PubMed Web of Science ®Google Scholar
• De Ronchi D, Fratiglioni L, Rucci P et al. The effect of education on dementia occurrence in an Italian population with middle to high socioeconomic status. Neurology50, 1231–1238 (1998).
   PubMed Web of Science ®Google Scholar
• Fratiglioni L, Grut M, Forsell Y et al. Prevalence of Alzheimer’s disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology41, 1886–1892 (1991).
   PubMed Web of Science ®Google Scholar
• Amaducci LA, Fratiglioni L, Rocca WA et al. Risk factors for clinically diagnosed Alzheimer’s disease: a case–control study of an Italian population. Neurology36, 922–931 (1986).
   PubMed Web of Science ®Google Scholar
• Bonaiuto S, Rocca WA, Lippi A et al. Education and occupation as risk factors for dementia: a population-based case–control study. Neuroepidemiology14, 101–109 (1995).
   PubMed Web of Science ®Google Scholar
• Letenneur L, Launer LJ, Andersen K et al. Education and the risk for Alzheimer’s disease: sex makes a difference. EURODEM pooled analyses. EURODEM Incidence Research Group. Am. J. Epidemiol.151, 1064–1071 (2000).
   PubMedGoogle Scholar
• Di Carlo A, Baldereschi M, Amaducci L et al. Incidence of dementia, Alzheimer’s disease, and vascular dementia in Italy. The ILSA Study. J. Am. Geriatr. Soc.50, 41–48 (2002).
   PubMed Web of Science ®Google Scholar
• Evans DA, Hebert LE, Beckett LA et al. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch. Neurol.54, 1399–1405 (1997).
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AL, Kuller LH, Ives DG et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J. Am. Geriatr. Soc.52, 195–204 (2004).
   PubMed Web of Science ®Google Scholar
• Graves AB, Mortimer JA, Larson EB, Wenzlow A, Bowen JD, McCormick WC. Head circumference as a measure of cognitive reserve. Association with severity of impairment in Alzheimer’s disease. Br. J. Psychiatry169, 86–92 (1996).
   PubMedGoogle Scholar
• Cobb JL, Wolf PA, Au R, White R, D’Agostino RB. The effect of education on the incidence of dementia and Alzheimer’s disease in the Framingham Study. Neurology45, 1707–1712 (1995).
   PubMed Web of Science ®Google Scholar
• Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer’s disease: the Baltimore Longitudinal Study of Aging. Neurology54, 2072–2077 (2000).
   PubMed Web of Science ®Google Scholar
• Schmand B, Smit JH, Geerlings MI, Lindeboom J. The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis. Psychol. Med.27, 1337–1344 (2000).
   Google Scholar
• Paykel ES, Brayne C, Huppert FA et al. Incidence of dementia in a population older than 75 years in the United Kingdom. Arch. Gen. Psychiatry51, 325–332 (1994).
   PubMedGoogle Scholar
• Panza F, Capurso C, D’Introno A et al. Mediterranean diet, mild cognitive impairment, and Alzheimer’s disease. Exp. Gerontol.42, 6–7 (2007).
   PubMedGoogle Scholar
• Solfrizzi V, Colacicco AM, D’Introno A et al. Dietary polyunsaturated fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging.Exp. Gerontol.41, 619–627 (2006).
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Colacicco AM, D’Introno A et al. Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol. Aging27, 1694–1704 (2006).
   PubMed Web of Science ®Google Scholar
• Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T et al. ω-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD Study: a randomized double-blind trial. Arch. Neurol.63, 1402–1408 (2006).
   PubMed Web of Science ®Google Scholar
• Greenwood CE, Winocur G. Cognitive impairment in rats fed high-fat diets: a specific effect of saturated fatty-acid intake. Behav. Neurosci.110, 451–459 (1996).
   PubMed Web of Science ®Google Scholar
• Winocur G, Greenwood CE. The effects of high fat diets and environmental influences on cognitive performance in rats. Behav. Brain Res.101, 153–161 (1999).
   PubMed Web of Science ®Google Scholar
• Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann. Neurol.42, 776–782 (1997).
   PubMed Web of Science ®Google Scholar
• Panza F, Solfrizzi V, Colacicco AM et al. Mediterranean diet and cognitive decline. Public Health Nutr.7, 959–963 (2004).
   PubMed Web of Science ®Google Scholar
• Perrig WJ, Perrig P, Stehelin B. The relation between antioxidants and memory performance in the old and very old. J. Am. Geriatr. Soc.45, 718–724 (1997).
   PubMed Web of Science ®Google Scholar
• Perkins AJ, Hendrie HC, Callahan CM et al. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol.150, 37–44 (1999).
   PubMed Web of Science ®Google Scholar
• Paleologos M, Cumming RG, Lazarus R. Cohort study of vitamin C intake and cognitive impairment. Am. J. Epidemiol.148, 45–50 (1998).
   PubMed Web of Science ®Google Scholar
• Riggs KM, Spiro A III, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine in cognitive performance in the Normative Aging Study. Am. J. Clin. Nutr.63, 306–314 (1996).
   PubMed Web of Science ®Google Scholar
• Tucker DM, Penland JG, Sandstead HH, Milne DB, Heck DG, Klevay LM. Nutrition status and brain function in aging. Am. J. Clin. Nutr.52, 93–102 (1990).
   PubMed Web of Science ®Google Scholar
• La Rue A, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY, Garry PJ. Nutritional status and cognitive functioning in a normally aging sample: a 6-year reassessment. Am. J. Clin. Nutr.65, 20–29 (1997).
   PubMed Web of Science ®Google Scholar
• Martin DC, Francis J, Protetch J, Huff FJ. Time dependency of cognitive recovery with cobalamin replacement: report a pilot study. J. Am. Geriatr. Soc.40, 168–172 (1992).
   PubMed Web of Science ®Google Scholar
• Joseph JA, Shukitt-Hale B, Denisova NA et al. Reversals of age-related declines in neuronal signal-transduction, cognitive and motor behavioral deficits with blueberry, spinach or strawberry, dietary supplementation. J. Neurosci.19, 8114–8121 (1999).
   PubMed Web of Science ®Google Scholar
• Morris MS. Homocysteine and Alzheimer’s disease. Lancet Neurol.2425–428 (2003).
   PubMed Web of Science ®Google Scholar
• Panza F, Solfrizzi V, D’Introno A, Capurso S, Capurso A. The role of micronutrients in cognitive decline and dementia. In: Diet and Cognitive Decline. Panza F, Solfrizzi V, Capurso A (Eds). Nova Science Publishers, Inc., NY, USA 35–58 (2004).
   Google Scholar
• Seshadri S, Beiser A, Selhub J et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N. Engl. J. Med.346, 476–483 (2002).
   PubMed Web of Science ®Google Scholar
• Quadri P, Fragiacomo C, Pezzati R et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr.80, 114–122 (2004).
   PubMed Web of Science ®Google Scholar
• Kruman II, Kumaravel TS, Lohani A et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s disease. J. Neurosci.22, 1752–1762 (2002).
   PubMed Web of Science ®Google Scholar
• Pradignac A, Schlienger JL, Velten M, Mejean L. Relationships between macronutrient intake, handicaps, and cognitive impairments in free living elderly people. Aging Clin. Exp. Res.7, 67–74 (1995).
   Web of Science ®Google Scholar
• Del Parigi A, Panza F, Capurso C, Solfrizzi V. Nutritional factors, cognitive decline, and dementia. Brain Res. Bull.69, 1–19 (2006).
   PubMed Web of Science ®Google Scholar
• Dye L, Lluch A, Blundell JE. Macronutrients and mental performance. Nutrition16, 1021–1034 (2000).
   PubMed Web of Science ®Google Scholar
• Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological dependence on plasma tryptophan levels. Science173, 149–152 (1971).
   PubMed Web of Science ®Google Scholar
• Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science178, 414–416 (1972).
   PubMed Web of Science ®Google Scholar
• Teff KL, Young SN, Blundell JE. The effect of protein or carbohydrate breakfasts on subsequent plasma amino acid levels, satiety and nutrient selection in normal males. Pharmacol. Biochem. Behav.34, 829–837 (1989).
   PubMed Web of Science ®Google Scholar
• Ashley DV, Liardon R, Leathwood PD. Breakfast meal composition influences plasmatryptophan to large neutral amino acid ratios of healthy lean young men. J. Neural. Transm.63, 271–283 (1985)
   PubMed Web of Science ®Google Scholar
• Anderson IM, Parry-Billings M, Newsholme EA, Fairburn CG, Cowen PJ. Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol. Med.20, 785–791 (1990).
   PubMed Web of Science ®Google Scholar
• Kaye WH, Gwirtsman HE, Brewerton TD, George DT, Wurtman RJ. Bingeing behavior and plasma amino acids: a possible involvement of brain serotonin in bulimia nervosa. Psychiatry Res.23, 31–43 (1988).
   PubMed Web of Science ®Google Scholar
• Ortega RM, Requejo AM, Andres P et al. Dietary intake and cognitive function in a group of elderly people. Am. J. Clin. Nutr.66, 803–809 (1997).
   PubMed Web of Science ®Google Scholar
• Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev.51, 83–133 (1999).
   PubMed Web of Science ®Google Scholar
• Jarvis MJ. Does caffeine enhance absolute levels of cognitive performance? Psychopharmacology110, 45–52 (1993).
   PubMed Web of Science ®Google Scholar
• Herbert LE, Scherr PA, Beckett LA et al. Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of older persons. Am. J. Epidemiol.137, 881–891 (1993).
   PubMed Web of Science ®Google Scholar
• Launer LJ, Feskens EJ, Kalmijn S, Kromhout D. Smoking, drinking, and thinking. The Zutphen Elderly Study. Am. J. Epidemiol.143, 219–227 (1996).
   PubMed Web of Science ®Google Scholar
• Dufouil C, Ducimetiere P, Alperovitch A. Sex differences in the association between alcohol consumption and cognitive performance. EVA Study Group. Epidemiology of Vascular Aging. Am. J. Epidemiol.146, 405–412 (1997).
   PubMed Web of Science ®Google Scholar
• Edelstein SL, Kritz-Silverstein D, Barrett-Connor E. Prospective association of smoking and alcohol use with cognitive function in an elderly cohort. J. Womens Health.7, 1271–1281 (1998).
   PubMed Web of Science ®Google Scholar
• Leibovici D, Ritchie K, Ledesert B, Touchon J. The effects of wine and tobacco consumption on cognitive performance in the elderly: a longitudinal study of relative risk. Int. J. Epidemiol.28, 77–81 (1999).
   PubMed Web of Science ®Google Scholar
• Elias PK, Elias MF, D’Agostino RB, Silbershatz H, Wolf PA. Alcohol consumption and cognitive performance in the Framingham Heart Study. Am. J. Epidemiol.150, 580–589 (1999).
   PubMed Web of Science ®Google Scholar
• Galanis DJ, Joseph C, Masaki KH, Petrovich H, Ross GW, White L. A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu–Asia aging study. Am. J. Public Health90, 1254–1259 (2000).
   PubMed Web of Science ®Google Scholar
• Cervilla A, Prince M, Mann A. Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project. J. Neurol. Neurosurg. Psychiatry68, 622–626 (2000).
   PubMed Web of Science ®Google Scholar
• Cervilla JA, Prince M, Joels S, Lovestone S, Mann A. Long-term predictors of cognitive outcome in a cohort of older people with hypertension. Br. J. Psychiatry177, 66–71 (2000).
   PubMed Web of Science ®Google Scholar
• Kalmijn S, van Boxtel MPJ, Verschuren MVM, Jolles J, Launer LJ. Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age. Am. J. Epidemiol.156, 936–944 (2002).
   PubMed Web of Science ®Google Scholar
• Leroi I, Sheppard JM, Lyketsos CG. Cognitive function after 11.5 years of alcohol use: relation to alcohol use. Am. J. Epidemiol.156, 747–752 (2002).
   PubMed Web of Science ®Google Scholar
• Anttila T, Helkala EL, Viitanen M et al. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. Br. Med. J.329(7465), 539(2004).
   PubMed Web of Science ®Google Scholar
• Espeland MA, Gu L, Masaki KH et al. Association between reported alcohol intake and cognition: results from the Women’s Health Initiative Memory Study. Am. J. Epidemiol.161, 228–238 (2005).
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, D’Introno A, Colacicco AM et al. for the Italian Longitudinal Study on Aging Working Group. Alcohol consumption, mild cognitive impairment, and progression to dementia. Neurology68, 1790–1799 (2007).
   PubMed Web of Science ®Google Scholar
• Fillmore MT, Carscadden JL, Vogel-Sprott M. Alcohol, cognitive impairment and expectancies. J. Stud. Alcohol59, 174–179 (1998).
   PubMed Web of Science ®Google Scholar
• Millar K, Hammersley RH, Finnigan F. Reduction of alcohol-induced performance impairment by prior ingestion of food. Br. J. Psychol.83(Pt 2), 261–278 (1992).
   PubMed Web of Science ®Google Scholar
• Lloyd HM, Rogers PJ. Mood and cognitive performance improved by a small amount of alcohol given with a lunchtime meal. Behav. Pharmacol.8, 188–195 (1997).
   PubMedGoogle Scholar
• Finnigan F, Hammersley R, Millar K. Effects of meal composition on blood alcohol level, psychomotor performance and subjective state after ingestion of alcohol. Appetite31, 361–375 (1998).
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Colacicco AM, D’Introno A et al. Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia. J. Alzheimers Dis.10, 303–330 (2006).
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, D’Introno A, Colacicco AM et al. Lifestyle-related factors, alcohol consumption, and mild cognitive impairment. J. Am. Geriatr. Soc.55, 1679–1681 (2007).
   PubMed Web of Science ®Google Scholar
• Panza F, Capurso C, Solfrizzi V. Cardiovascular factors and cognitive impairment: a role for unsaturated fatty acids and mediterranean diet? Am. J. Cardiol.98, 1120–1121 (2006).
   PubMedGoogle Scholar
• Skoog I, Lernfelt B, Landahl S et al. 15-year longitudinal study of blood pressure and dementia. Lancet347, 1141–1145 (1996).
   PubMed Web of Science ®Google Scholar
• Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology53, 1937–1942 (1999).
   PubMed Web of Science ®Google Scholar
• Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke28, 316–321 (1997).
   PubMed Web of Science ®Google Scholar
• Hofman A, Ott A, Breteler MM et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet349, 151–154 (1997).
   PubMed Web of Science ®Google Scholar
• Mungas D, Cooper JK, Weiler PG, Gietzen D, Franzi C, Bernick C. Dietary preference for sweet foods in patients with dementia. J. Am. Geriatr. Soc.38, 999–1007 (1990).
   PubMed Web of Science ®Google Scholar
• Wurtman RJ. Effects of their nutrient precursors on the synthesis and release of serotonin, the catecholamines, and acetylcholine: implications for behavioral disorders. Clin. Neuropharmacol.11(Suppl. 1), S187 (1988).
   Google Scholar
• Hoyer S. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J. Neural Transm.105, 415–422 (1998).
   PubMed Web of Science ®Google Scholar
• Hoyer S. The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J. Neural Transm.109, 341–360 (2002).
   PubMed Web of Science ®Google Scholar
• Munch G, Schinzel R, Loske C et al. Alzheimer’s disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J. Neural Transm.105, 439–461 (1998).
   PubMed Web of Science ®Google Scholar
• Otsuka M, Yamaguchi K, Ueki A. Similarities and differences between Alzheimer’s disease and vascular dementia from the viewpoint of nutrition. Ann. NY Acad. Sci.977, 155–161 (2002).
   PubMed Web of Science ®Google Scholar
• Ross GW, Petrovitch H, White LR et al. Characterization of risk factors for vascular dementia. The Honolulu–Asia Aging Study. Neurology53, 337–343 (1999).
   PubMedGoogle Scholar
• Huijbregts PP, Feskens EJ, Rasanen L et al. Dietary intake in five ageing cohorts of men in Finland, Italy, and the Netherlands. Eur. J. Clin. Nutr.49, 852–860 (1995).
   PubMed Web of Science ®Google Scholar
• Huijbregts PP, Feskens EJ, Rasanen L et al. Dietary patterns and cognitive function in elderly men in Finland, Italy, and the Netherlands. Eur. J. Clin. Nutr.52, 826–831 (1998).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gross M, Marcos A, Pietrzik K. Nutrition and cognitive impairment in the elderly. Br. J. Nutr.86, 313–321 (1997).
   Google Scholar
• Fekkes D, van der Cammen TJ, van Loon CP et al. Abnormal amino acid metabolism in patients with early stage Alzheimer dementia. J. Neural. Transm.105, 287–294 (1998).
   PubMed Web of Science ®Google Scholar
• Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science178, 414–416 (1972).
   PubMed Web of Science ®Google Scholar
• Riedel WJ, Jorissen BL. Nutrients, age and cognitive function. Curr. Opin. Clin. Nutr. Metab. Care1, 579–585 (1998).
   PubMedGoogle Scholar
• Rogers RD, Everitt BJ, Baldacchino A et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology20, 322–339 (1999).
   PubMed Web of Science ®Google Scholar
• Hendrie HC, Osuntokun BO, Hall KS et al. Prevalence of Alzheimer’s disease and dementia in two communities: Nigerian Africans and African Americans. Am. J. Psychiatry152, 1485–1492 (1995).
   PubMed Web of Science ®Google Scholar
• White L, Petrovitch H, Ross GW et al. Prevalence of dementia in older Japanese–American men in Hawaii. JAMA276, 955–960 (1996).
   PubMed Web of Science ®Google Scholar
• Grant WB. Dietary links to Alzheimer’s disease. Alz. Dis. Rev.2, 42–55 (1997).
   Google Scholar
• Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann. Neurol.42, 776–782 (1997).
   PubMed Web of Science ®Google Scholar
• Morris MC, Evans DA, Bienias JL et al. Dietary fats and the risk of incident Alzheimer disease. Arch. Neurol.60, 194–200 (2003).
   PubMed Web of Science ®Google Scholar
• Morris MC, Evans DA, Bienias JL et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol.60, 940–946 (2003).
   PubMed Web of Science ®Google Scholar
• Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S. Fish, meat, and risk of dementia: cohort study. Br. Med. J.325, 932–933 (2002).
   PubMed Web of Science ®Google Scholar
• Larrieu S, Letenneur L, Helmer C, Dartigues JF, Barberger-Gateau P. Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J. Nutr. Health Aging8, 150–154 (2004).
   PubMedGoogle Scholar
• Luchsinger JA, Tang MX, Shea S, Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch. Neurol.59, 1258–1263 (2002).
   PubMedGoogle Scholar
• Solfrizzi V, Panza F, Torres F et al. High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology52, 1563–1569 (1999).
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, D’Introno A, Colacicco AM et al. Dietary fatty acids intake: possible role in cognitive decline and dementia. Exp. Gerontol.40, 257–270 (2005).
   PubMed Web of Science ®Google Scholar
• Grant WB. Dietary links to Alzheimer’s disease: 1999 Update. J. Alzheimer Dis.1, 197–201 (1999).
   PubMedGoogle Scholar
• Gibson RS. Content and bioavailability of trace elements in vegetarian diets. Am. J. Clin. Nutr.59(5 Suppl.), S1223–S1232 (1994).
   PubMed Web of Science ®Google Scholar
• Gibson RS, Heath AL, Limbaga ML, Prosser N, Skeaff CM. Are changes in food consumption patterns associated with lower biochemical zinc status among women from Dunedin, New Zealand? Br. J. Nutr.86, 71–80 (2001).
   PubMedGoogle Scholar
• Lonnerdal B. Dietary factors influencing zinc absorption. J. Nutr.130(5S Suppl.), S1378–S1383 (2000).
   PubMed Web of Science ®Google Scholar
• Farlow MR, Cummings JL. Effective pharmacologic management of Alzheimer’s disease. Am. J. Med.120, 388–397 (2007).
   PubMed Web of Science ®Google Scholar
• Korczyn AD, Vakhapova V. The prevention of the dementia epidemic. J. Neurol. Sci.257, 2–4 (2007).
   PubMed Web of Science ®Google Scholar
• Korczyn AD. The complex nosological concept of vascular dementia. J. Neurol. Sci.203–204, 3–6 (2002).
   PubMedGoogle Scholar
• Roman GC. Vascular dementia may be the most common form of dementia in the elderly. J. Neurol. Sci.203–204, 7–10 (2002).
   PubMedGoogle Scholar
• Kalaria RN. Small vessel disease and Alzheimer’s dementia: pathological considerations. Cerebrovasc. Dis. Suppl.2, 48–52 (2002).
   Google Scholar
• DeKosky ST. Statin therapy in the treatment of Alzheimer disease: what is the rationale? Am. J. Med.118(Suppl. 2A), 48–53 (2005).
   PubMedGoogle Scholar
• Sparks DL, Sabbagh MN, Connor DJ et al. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch. Neurol.62, 753–757 (2005).
   PubMed Web of Science ®Google Scholar
• Lim WS, Gammack JK, Van Niekerk J, Dangour AD. Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst. Rev.25, CD005379 (2006).
   Google Scholar
• Panza F, Capurso C, D’Introno A et al. Dietary polyunsaturated fatty acid supplementation, pre-dementia syndromes, and Alzheimer’s disease. J. Am. Geriatr. Soc.55, 469–470 (2007).
   PubMedGoogle Scholar
• Kotani S, Sakaguchi E, Warashina S et al. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci. Res.56, 159–164 (2006).
   PubMed Web of Science ®Google Scholar
• Mielke R, Moller HJ, Erkinjuntti T, Rosenkranz B, Rother M, Kittner B. Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of Phase I and Phase II clinical trials. Alzheimer Dis. Assoc. Disord.12(Suppl. 2), S29–S35 (1998).
   Google Scholar
• de Mendonca A, Sebastiao AM, Ribeiro JA. Adenosine: does it have a neuroprotective role after all? Brain. Res. Rev.33, 258–274 (2000).
   PubMedGoogle Scholar
• Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev.51, 83–133 (1999).
   PubMed Web of Science ®Google Scholar
• Maia L, de Mendonca A. Does caffeine intake protect from Alzheimer’s disease? Eur. J. Neurol.9, 377–382 (2002).
   Google Scholar
• Ross GW, Abbott RD, Petrovitch H et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA283, 2674–2679 (2000).
   PubMed Web of Science ®Google Scholar
• Orgogozo JM, Dartigues JF, Lafont S et al. Wine consumption and the elderly: a prospective community study in the Bordeaux area. Rev. Neur.153, 185–192 (1997).
   PubMed Web of Science ®Google Scholar
• Serafini M, Maiani G, Ferro-Luzzi A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J. Nutr.128, 1003–1007 (1998).
   PubMed Web of Science ®Google Scholar
• Ruitenberg A, van Swieten JC, Witteman JC et al. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet359, 281–286 (2002).
   PubMed Web of Science ®Google Scholar
• Mukamal KJ, Kuller LH, Fitzpatrick AL, Longstreth WT Jr, Mittleman MA, Siscovick DS. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA289, 1405–1413 (2003).
   PubMed Web of Science ®Google Scholar
• Truelsen T, Thudium D, Grønbæk M. Amount and type of alcohol and risk of dementia: the Copenhagen city heart study. Neurology59, 1313–1319 (2002).
   PubMed Web of Science ®Google Scholar
• Dufouil C, Tzourio C, Brayne C, Berr C, Amouyel P, Alperovitch A. Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology11, 280–284 (2000).
   PubMed Web of Science ®Google Scholar
• Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R. Alcohol intake and risk of dementia. J. Am. Geriatr. Soc.52, 540–546 (2004).
   PubMed Web of Science ®Google Scholar
• Lindsay J, Laurin D, Verreault R et al. Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian study of health and aging. Am. J. Epidemiol.156, 445–453 (2002).
   PubMed Web of Science ®Google Scholar
• Huang W, Qiu C, Winblad B, Fratiglioni L. Alcohol consumption and incidence of dementia in a community sample aged 75 years and older. J. Clin. Epidemiol.55, 959–964 (2002).
   PubMed Web of Science ®Google Scholar
• Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet.1, 507–537 (2000).
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Panza F, Capurso A. The role of diet in cognitive decline. J. Neural Transm.110, 95–110 (2003).
   PubMed Web of Science ®Google Scholar
• Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer’s disease. Ann. Neurol.59, 912–921 (2006).
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Capurso C, Panza F. Adherence to a Mediterranean dietary pattern and risk for Alzheimer’s disease. Ann. Neurol.60, 620 (2006).
   PubMedGoogle Scholar
• Trichopoulou A, Kouris-Blazos A, Wahlqvist ML et al. Diet and overall survival in elderly people, Br. Med. J.311, 1457–1460 (1995).
   PubMed Web of Science ®Google Scholar
• Hu FB, Bronner L, Willett WC et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA287, 1815–1821 (2002).
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Capurso C, D’Introno A, Colacicco AM, Capurso A, Panza F. Whole-diet approach and risk of chronic disease: limits and advantages. J. Am. Geriatr. Soc.54, 1800–1802 (2006).
   PubMed Web of Science ®Google Scholar
• Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N. Engl. J. Med.348, 2599–2608 (2003).
   PubMed Web of Science ®Google Scholar
• Small GW, Silverman DH, Siddarth P et al. Effects of a 14-day healthy longevity lifestyle program on cognition and brain function, Am. J. Geriatr. Psychiatry14, 538–545 (2006).
   Google Scholar
• Panza F, Capurso C, D’Introno A et al. Possible role of unsaturated fatty acids in a 14-day healthy longevity lifestyle program. Am. J. Geriatr. Psychiatry15, 266 (2007).
   PubMedGoogle Scholar
• Rejeski WJ, Fielding RA, Blair SN et al. The lifestyle interventions and independence for elders (LIFE) pilot study: design and methods. Contemp. Clin. Trials26, 141–154 (2005).
   PubMed Web of Science ®Google Scholar
• LIFE Study Investigators, Pahor M, Blair SN, Espeland M et al. Effects of a physical activity interventions on measures of physical performance: results of the Lifestyle Interventions For independence in Elders Pilot (LIFE-P) study. J. Gerontol. A Biol. Sci. Med. Sci.61, 1157–1165 (2006).
   PubMed Web of Science ®Google Scholar
• Yaffe K, Barnes D, Nevitt M, Lui LY, Covinsky K. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch. Intern. Med.161, 1703–1708 (2001).
   PubMed Web of Science ®Google Scholar
• Barnes DE, Yaffe K, Satariano WA, Tager IB. A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults. J. Am. Geriatr. Soc.51, 459–465 (2003).
   PubMed Web of Science ®Google Scholar
• Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch. Neurol.58, 498–504 (2001).
   PubMed Web of Science ®Google Scholar
• Abbott RD, White LR, Ross GW, Masaki KH, Curb JD, Petrovitch H. Walking and dementia in physically capable elderly men. JAMA292, 1447–1453 (2004).
   PubMed Web of Science ®Google Scholar
• Larson EB, Wang L, Bowen JD et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med.144, 73–81 (2006).
   PubMed Web of Science ®Google Scholar
• Dustman RE, Ruhling RO, Russell EM et al. Aerobic exercise training and improved neuropsychological function of older individuals. Neurobiol. Aging5, 35–42 (1984).
   PubMed Web of Science ®Google Scholar
• Kramer AF, Hahn S, Cohen NJ et al. Ageing, fitness and neurocognitive function. Nature400, 418–419 (1999).
   PubMed Web of Science ®Google Scholar
• Rikli RE, Edwards DJ. Effects of a three-year exercise program on motor function and cognitive processing speed in older women. Res. Q Exerc. Sport62, 61–67 (1991).
   PubMed Web of Science ®Google Scholar
• Hill RD, Storandt M, Malley M. The impact of long-term exercise training on psychological function in older adults. J. Gerontol.48, 12–17 (1993).
   PubMedGoogle Scholar
• Madden DJ, Blumenthal JA, Allen PA, Emery CF. Improving aerobic capacity in healthy older adults does not necessarily lead to improved cognitive performance. Psychol. Aging4, 307–320 (1989).
   PubMed Web of Science ®Google Scholar
• Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol. Sci.14, 125–130 (2003).
   PubMed Web of Science ®Google Scholar
• West RL. An application of prefrontal cortex function theory to cognitive aging. Psychol. Bull.120, 272–292 (1996).
   PubMed Web of Science ®Google Scholar
• Kramer AF, Humphrey DG, Larish JF, Logan GD, Strayer DL. Aging and inhibition: beyond a unitary view of inhibitory processing in attention. Psychol. Aging9, 491–512 (1994).
   PubMed Web of Science ®Google Scholar
• Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch. Neurol.58, 498–504 (2001).
   PubMed Web of Science ®Google Scholar
• Lindsay J, Laurin D, Verreault R et al. Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging. Am. J. Epidemiol.156, 445–453 (2002).
   PubMed Web of Science ®Google Scholar
• Podewills LJ, Guallar E, Kuller LH et al. Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am. J. Epidemiol.161, 639–651 (2005).
   PubMedGoogle Scholar
• Verghese J, Lipton RB, Katz MJ et al. Leisure activities and the risk of dementia in the elderly. N. Engl. J. Med.348, 2508–2516 (2003).
   PubMed Web of Science ®Google Scholar
• Abbott RD, White LR, Ross GW et al. Walking and dementia in physically capable elderly men. JAMA292, 1447–1453 (2004).
   PubMed Web of Science ®Google Scholar
• Broe GA, Creasey H, Jorm AF et al. Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumption. Aust. NZ J. Public Health22, 621–623 (1998).
   PubMed Web of Science ®Google Scholar
• Wilson RJ, Bennett DA, Bienias JL et al. Cognitive activity and incident AD in a population-based sample of older persons. Neurology59, 1910–1914 (2002).
   PubMed Web of Science ®Google Scholar
• Fabrigoule C, Letenneur L, Dartigues JF et al. Social and leisure activities and risk of dementia: a prospective longitudinal study. J. Am. Geriatr. Soc.43, 485–490 (1995).
   PubMed Web of Science ®Google Scholar
• Wang HX, Karp A, Winblad B, Fratiglioni L. Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen Project. Am. J. Epidemiol.155, 1081–1087 (2002).
   PubMed Web of Science ®Google Scholar
• Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G. Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J. Am. Geriatr. Soc.51, 410–414 (2003).
   PubMed Web of Science ®Google Scholar
• Rovio S, Kareholt I, Helkala EL et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer’s disease. Lancet Neurol.4, 705–711 (2005).
   PubMed Web of Science ®Google Scholar
• Friedland RP, Fritsch T, Smyth KA et al. Patients with Alzheimer’s disease have reduced activities in midlife compared with healthy control-group members. Proc. Natl Acad. Sci. USA98, 3440–3445 (2001).
   PubMed Web of Science ®Google Scholar
• Verghese J, LeValley A, Derby C et al. Leisure activities and the risk of amnestic mild cognitive impairment in the elderly. Neurology66, 821–827 (2006).
   PubMed Web of Science ®Google Scholar
• Wilson RS, Mendes De Leon CF, Barnes LL et al. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA287, 742–748 (2002).
   PubMed Web of Science ®Google Scholar
• Noah A, Truswell AS. There are many Mediterranean diets. Asia Pac. J. Clin. Nutr.10(1), 2–9 (2001).
   PubMedGoogle Scholar
• Gascon-Bayarri J, Rene R, Del Barrio JL et al. Prevalence of dementia subtypes in El Prat de Llobregat, Catalonia, Spain: the PRATICON study. Neuroepidemiology28, 224–234 (2007).
   PubMed Web of Science ®Google Scholar
• Letenneur L, Dequae L, Jacqmin H et al. [Prevalence of dementia in Gironde (France)] Rev. Epidemiol. Sante Publique41, 139–145 (1993).
   PubMedGoogle Scholar
• The Italian Longitudinal Study on Aging Working Group. Prevalence of chronic diseases in older Italians: comparing self-reported and clinical diagnoses. Int. J. Epidemiol.26, 995–1002 (1997).
   PubMed Web of Science ®Google Scholar
• Argyriadou S, Melissopoulou H, Krania E, Karagiannidou A, Vlachonicolis I, Lionis C. Dementia and depression: two frequent disorders of the aged in primary health care in Greece. Fam. Pract.18, 87–91 (2001).
   PubMed Web of Science ®Google Scholar
• Keskinoglu P, Giray H, Picakciefe M, Bilgic N, Ucku R. The prevalence and risk factors of dementia in the elderly population in a low socio-economic region of Izmir, Turkey. Arch. Gerontol. Geriatr.43, 93–100 (2006).
   PubMed Web of Science ®Google Scholar
• Briante R, Febbraio F, Nucci R. Antioxidant properties of low molecular weight phenols present in the Mediterranean diet. J. Agric. Food Chem.51, 6975–6981 (2003).
   PubMed Web of Science ®Google Scholar
• Joseph JA, Shukitt-Hale B, Denisova NA et al. Reversals of age-related declines in neuronal signal transduction, cognitive and motor behavioral deficits with blueberry, spinach or strawberry dietary supplementation. J. Neurosci.19, 8114–8121 (1999).
   PubMed Web of Science ®Google Scholar
• Deschamps V, Barberger-Gateau P, Peuchant E, Orgogozo JM. Nutritional factors in cerebral aging and dementia: epidemiological arguments for a role of oxidative stress. Neuroepidemiology20, 7–15 (2001).
   PubMed Web of Science ®Google Scholar
• Jones CB, Arai T, Rapoport SI. Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse. Neurochem. Res.22, 663–670 (1997).
   PubMed Web of Science ®Google Scholar
• Favrelere S, Stadelmann-Ingrand S, Huguet F et al. Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol. Aging21, 653–660 (2000).
   PubMed Web of Science ®Google Scholar
• Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J. Nutr. Health Aging8, 163–174 (2004).
   PubMedGoogle Scholar
• Bourre JM, Dumont OL, Clement ME, Durand GA. Endogenous synthesis cannot compensate for absence of dietary oleic acid in rats. J. Nutr.127, 488–493 (1997).
   PubMed Web of Science ®Google Scholar
• Williams P, Forsyth JS, DiMondugno MK, Varma S, Colvin M. Effects of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet352, 688–691 (1998).
   PubMedGoogle Scholar
• Delion S, Chalon S, Hearault J, Guilloteau D, Besnard J-C, Durand G. Chronic dietary-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J. Nutr.124, 2466–2476 (1994).
   PubMed Web of Science ®Google Scholar
• Horrocks LA, Yeo YK. Health benefits of docosahexaenoic acid [DHA]. Pharmacol. Res.40, 211–225 (1999).
   PubMed Web of Science ®Google Scholar
• Keli SO, Feskens EJ, Kromhout D. Fish consumption and risk of stroke. The Zutphen Study. Stroke25, 328–332 (1994).
   PubMed Web of Science ®Google Scholar
• Marchiali R, Barzi F, Bomba E et al. GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico [GISSI]-Prevenzione. Circulation105, 1897–1903 (2002).
   PubMedGoogle Scholar
• Panza F, D’Introno A, Colacicco AM et al. Vascular risk and genetics of sporadic late-onset Alzheimer’s disease. J. Neural. Transm.111, 69–89 (2004).
   PubMed Web of Science ®Google Scholar
• Crawford MA, Bloom M, Broadhurst CL et al. Evidence for the unique function of docosahexaenoic acid during the evolution of the modern hominid brain. Lipids34(Suppl.), S39–S47 (1999).
   PubMed Web of Science ®Google Scholar
• Alsted AL, Hoy CE. Fatty acid profiles of brain phospholipid subclasses of rats fed n-3 polyunsaturated fatty acids of marine or vegetable origin. A two generation study. Biochim. Biophys. Acta1125, 237–244 (1992).
   PubMedGoogle Scholar
• Reaven PD, Grasse BJ, Tribble DL. Effects of linoleate-enriched and oleate-enriched diets in combination with α-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler. Thromb.14, 557–566 (1994).
   PubMed Web of Science ®Google Scholar
• Blankenhorn DH, Johnson RL, Mack WJ, el Zein HA, Vailas LI. The influence of diet on the appearance of new lesions in human coronary arteries. JAMA263, 1646–1652 (1990).
   PubMed Web of Science ®Google Scholar
• de Lorgeril M, Salen P, Martin JL, Monjaud I, Boucher P, Mamelle N. Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. Arch. Intern. Med.158, 1181–1187 (1998).
   PubMed Web of Science ®Google Scholar
• McGeer PL, McGeer EG. The inflammatory response system of brain: Implications for therapy of Alzheimer and neurodegenerative diseases. Brain Res. Rev.21, 195–218 (1995).
   PubMed Web of Science ®Google Scholar
• Ambring A, Friberg P, Axelsen M et al. Effects of a Mediterranean-inspired diet on blood lipids, vascular function and oxidative stress in healthy subjects. Clin. Sci.106, 519–525 (2004).
   PubMed Web of Science ®Google Scholar
• Notkola IL, Sulkava R, Pekkanen J et al. Serum total cholesterol, apolipoprotein E e4 allele, and Alzheimer’s disease. Neuroepidemiology17, 14–20 (1998).
   PubMed Web of Science ®Google Scholar
• Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer’s disease: a case–control study. Neurology45, 1092–1096 (1995).
   PubMed Web of Science ®Google Scholar
• Kuusisto J, Koivisto K, Mykkanen L et al. Association between features of the insulin resistance syndrome and Alzheimer’s disease independently of apolipoprotein E4 phenotype: cross sectional population based study. Br. Med. J.315, 1045–1049 (1997).
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Panza F, D’Introno A et al. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry72, 732–736 (2002).
   PubMedGoogle Scholar
• Urakami K, Wada-Isoe K, Wakutani Y et al. Lipoprotein[a] phenotypes in patients with vascular dementia. Dement. Geriatr. Cogn. Disord.11, 135–138 (2000).
   PubMed Web of Science ®Google Scholar
• Kuo YM, Emmerling MR, Bisgaier CL et al. Elevated low-density lipoprotein in Alzheimer’s disease correlates with brain Ab 1–42 levels. Biochem. Biophys. Res. Comm.252, 711–715 (1998).
   PubMed Web of Science ®Google Scholar
• Palomaki H, Kaste M. Regular light-to-moderate intake of alcohol and the risk of ischemic stroke: is there a beneficial effect? Stroke24, 1828–1832 (1993).
   PubMed Web of Science ®Google Scholar
• den Heijer T, Vermeer SE, van Dijk EJ et al. Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia. Am. J. Clin. Nutr.80, 992–997 (2004).
   PubMed Web of Science ®Google Scholar
• Fadda F, Rossetti ZL. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog. Neurobiol.56, 385–431 (1998).
   PubMed Web of Science ®Google Scholar
• Ladolfi R, Steiner M. Ethanol raises prostacyclin level in vivo and in vitro. Blood64, 679–682 (1984).
   PubMedGoogle Scholar
• Rubin R, Rand ML. Alcohol and platelet function. Alcohol Clin. Exp. Res.18, 105–110 (1994).
   PubMed Web of Science ®Google Scholar
• Ridker PM, Vaughan DE, Stampfer MJ et al. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA272, 929–933 (1994).
   PubMed Web of Science ®Google Scholar
• Meade TW, Chakrabarti R, Haines AP et al. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br. Med. J.1, 153–156 (1979).
   PubMed Web of Science ®Google Scholar
• Gaziano JM, Buring JE, Breslow JL et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N. Engl. J. Med.329, 1829–1834 (1993).
   PubMed Web of Science ®Google Scholar
• Camargo CA Jr, Williams PT, Vranizan KM et al. The effect of moderate alcohol intake on serum apolipoproteins A-I and A-II. A controlled study. JAMA253. 2854–2857 (1985).
   PubMed Web of Science ®Google Scholar
• Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biologic pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation85, 910–915 (1992).
   PubMed Web of Science ®Google Scholar
• Howard A, Chopra M, Thurnman D et al. Red wine consumption an inhibition of LDL oxidation: What are the important components? Med. Hypotheses59, 101 (2002).
   PubMed Web of Science ®Google Scholar
• Bertelli AA, Migliori M, Panichi V et al. Oxidative stress and inflammatory reaction modulation by white wine. Ann. NY Acad. Sci.957, 295–301 (2002).
   PubMed Web of Science ®Google Scholar
• Serafini M, Maiani G, Ferro-Luzzi A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J. Nutr.128, 1003–1007 (1998).
   PubMed Web of Science ®Google Scholar
• Heinonen IM, Lehtonen PJ, Hopia AI. Antioxidant activity of berry and fruit wines and liquors. J. Agric. Food Chem.46, 25–31 (1998).
   PubMed Web of Science ®Google Scholar
• Anstey K, Christensen H. Education, activity, health, blood pressure and apolipoprotein E as predictors of cognitive change in old age: a review. Gerontology46, 163–177 (2000).
   PubMed Web of Science ®Google Scholar
• Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease. Lancet354, 919–920 (1999).
   PubMed Web of Science ®Google Scholar
• Colsher PL, Wallace RB. Epidemiologic considerations in studies of cognitive function in the elderly: methodology and nondementing acquired dysfunction. Epidemiol. Rev.13, 1–27 (1991).
   PubMed Web of Science ®Google Scholar
• Long DM. Aging in the nervous system. Neurosurgery17, 348–354 (1985).
   PubMed Web of Science ®Google Scholar
• Rogers RL, Meyer JS, Mortel KF. After reaching retirement age physical activity sustains cerebral perfusion and cognition. J. Am. Geriatr. Soc.38, 123–128 (1990).
   PubMed Web of Science ®Google Scholar
• Churchill JD, Galvez R, Colcombe S, Swain RA, Kramer AF, Greenough WT. Exercise, experience and the aging brain. Neurobiol. Aging23, 941–955 (2002).
   PubMed Web of Science ®Google Scholar
• Black JE, Isaacs KR, Anderson BJ, Alcantara AA, Greenough WT. Learning causes synaptogenesis, whereas motor activity causes angiogenesis, in cerebellar cortex of adult rats. Proc. Natl Acad. Sci. USA87, 5568–5572 (1990).
   PubMed Web of Science ®Google Scholar
• van Praag H, Christie BR, Sejnowski TJ, Gage FH. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc. Natl Acad. Sci. USA96, 13427–13431 (1999).
   PubMed Web of Science ®Google Scholar
• van Praag H, Shubert T, Zhao C, Gage FH. Exercise enhances learning and hippocampal neurogenesis in aged mice. J. Neurosci.25, 8680–8685 (2005).
   PubMed Web of Science ®Google Scholar
• Vaynman SS, Ying Z, Yin D, Gomez-Pinilla F. Exercise differentially regulates synaptic proteins associated to the function of BDNF. Brain Res.1070, 124–130 (2006).
   PubMed Web of Science ®Google Scholar
• Berchtold NC, Kesslak JP, Pike CJ, Adlard PA, Cotman CW. Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus. Eur. J. Neurosci.14, 1992–2002 (2001).
   PubMed Web of Science ®Google Scholar
• Carro E, Trejo JL, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J. Neurosci.21, 5678–5684 (2001).
   PubMed Web of Science ®Google Scholar
• Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci.25, 295–301 (2002).
   PubMed Web of Science ®Google Scholar
• Adlard PA, Perreau VM, Pop V, Cotman CW. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer’s disease. J. Neurosci.25, 4217–4221 (2005).
   PubMed Web of Science ®Google Scholar
• Radak Z, Kaneko T, Tahara S et al. Regular exercise improves cognitive function and decreases oxidative damage in rat brain. Neurochem. Int.38, 17–23 (2001).
   PubMed Web of Science ®Google Scholar
• Church TS, Barlow CE, Earnest CP, Kampert JB, Priest EL, Blair SN. Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler. Thromb. Vasc. Biol.22, 1869–1876 (2002).
   PubMed Web of Science ®Google Scholar
• Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am. J. Cardiol.84, 1018–1022 (1999).
   PubMed Web of Science ®Google Scholar
• Das UN. Anti-inflammatory nature of exercise. Nutrition20, 323–326 (2004).
   PubMed Web of Science ®Google Scholar
• Grammas P, Ovase R. Inflammatory factors are elevated in brain microvessels in Alzheimer’s disease. Neurobiol. Aging22, 837–842 (2001).
   PubMed Web of Science ®Google Scholar
• Yaffe K, Lindquist K, Penninx BW et al. Inflammatory markers and cognition in well-functioning African–American and white elders. Neurology61, 76–80 (2003).
   PubMed Web of Science ®Google Scholar
• Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev.7, 284–301 (1986).
   PubMed Web of Science ®Google Scholar
• Belanoff JK, Gross K, Yager A, Schatzberg AF. Corticosteroids and cognition. J. Psychiatr. Res.35, 127–145 (2001).
   PubMed Web of Science ®Google Scholar
• Del Ser T, Hachinski V, Merskey H, Munoz DG. An autopsy-verified study of the effect of education on degenerative dementia. Brain122(Pt 12), 2309–2319 (1999).
   PubMed Web of Science ®Google Scholar
• Katzman R. Education and the prevalence of dementia and Alzheimer’s disease. Neurology43, 13–20 (1993).
   PubMed Web of Science ®Google Scholar
• Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J. Int. Neuropsychol. Soc.8, 448–460 (2002).
   PubMed Web of Science ®Google Scholar
• Lands WEM, Pawlosky RJ, Salem N Jr. Alcoholism, antioxidant status, and essential fatty acids. In: Antioxidant Status, Diet, Nutrition, and Health. Papas AM (Ed). CRC Press, FL, USA299–344 (1999).
   Google Scholar
• Harris RA, Baxter DM, Mitchell MA, Hitzemann RJ. Physical properties and lipid composition of brain membranes from ethanol tolerant dependent mice. Mol. Pharmacol.25, 401–409 (1984).
   PubMed Web of Science ®Google Scholar
• Pawlosky RJ, Salem N Jr. Ethanol exposure causes a decrease in docosahexaenoic acid and an increase in docosapentaenoic acid in feline brains and retinas. Am. J. Clin. Nutr.61, 1284–1289 (1995).
   PubMed Web of Science ®Google Scholar
• Salem N Jr, Reyzer M, Karanian J. Losses of arachidonic acid in rat liver after alcohol inhalation. Lipids31(Suppl.), S153–S156 (1996).
   Web of Science ®Google Scholar
• Debski B, Bertrandt J, Klos A, Gralak M. The influence of folic acid, vitamins B2 and B6 supplementation on feed intake, body and organs weight, and liver fatty acids composition of rats subjected to 3 months moderate protein deprivation. J. Vet. Med. A Physiol. Pathol. Clin. Med.54, 57–61 (2007).
   PubMedGoogle Scholar
• Eritsland J. Safety considerations of polyunsaturated fatty acids. Am. J. Clin. Nutr.71(1 Suppl.), S197–S201 (2000).
   PubMed Web of Science ®Google Scholar
• Conquer JA, Roelfsema H, Zecevic J, Graham TE, Holub BJ. Effect of exercise on FA profiles in n-3 FA-supplemented and -nonsupplemented premenopausal women. Lipids37, 947–951 (2002).
   PubMedGoogle Scholar
• Bopp M, Lovelady C, Hunter C, Kinsella T. Maternal diet and exercise: effects on long-chain polyunsaturated fatty acid concentrations in breast milk. J. Am. Diet. Assoc.105, 1098–1103 (2005).
   PubMedGoogle Scholar
• Ball K, Berch DB, Helmers KF et al. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA288, 2271–2281 (2002).
   PubMed Web of Science ®Google Scholar
• Spector A, Thorgrimsen L, Woods B et al. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial. Br. J. Psychiatry183, 248–254 (2003).
   PubMed Web of Science ®Google Scholar